Biomerica, Inc. (BMRA)

Market Cap	11.99M
Revenue (ttm)	5.41M
Net Income (ttm)	-6.35M
Shares Out	16.82M
EPS (ttm)	-0.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	658,345
Open	0.758
Previous Close	0.722
Day's Range	0.670 - 0.800
52-Week Range	0.670 - 2.130
Beta	-1.04
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 12, 2024

About BMRA

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 62
• Stock Exchange: NASDAQ
• Ticker Symbol: BMRA

Financial Performance

In 2023, Biomerica's revenue was $5.34 million, a decrease of -71.71% compared to the previous year's $18.87 million. Losses were -$7.14 million, 57.6% more than in 2022.